CIK 0001660334
- Non-accelerated filer
- Smaller reporting company
Verrica Pharmaceuticals Inc.
Sign in to watch- Ticker
- VRCA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463137900
- Phone
- +1 484-453-3300
- Business address
- 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
- 4 Open-market buy Director bought 22,921,348 shares
- 4 Grant or award Interim CFO acquired 54,267 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Gift Director gave 2,675,611.25 shares (gift)
- 4 Open-market sale CHIEF LEGAL OFFICER sold 35,713 shares at an average $2.61 ($93,091)
- 4 Open-market sale Chief Medical Officer sold 13,489 shares at an average $2.61 ($35,161)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 33,702 shares at an average $2.61 ($87,849)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 29,719 shares at an average $2.61 ($77,473)
- 4 Open-market sale PRESIDENT AND CEO sold 34,000 shares at an average $2.61 ($88,636)
- 4 Open-market sale PRESIDENT AND CEO sold 32,623 shares at an average $7.06 ($230,306)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 25,576 shares at an average $7.06 ($180,557)
- 4 Open-market sale Chief Medical Officer sold 18,507 shares at an average $7.06 ($130,653)
- 4 Open-market sale CHIEF LEGAL OFFICER sold 21,740 shares at an average $7.06 ($153,477)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 13 · 253 filings